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Background: We aimed to determine whether no reflow/slow flow phenomenon during elective percutaneous coronary interventions (PCI’s) is 
associated with early, in-hospital complications.
Methods: Retrospective analysis of elective PCI’s performed at our hospital on 3542 patients (mean age 65 years, 72% males) between 
01/01/2004 and 01/31/2009 identified 173 patients who received intracoronary (IC) or intra-graft (IG) adenosine, nicardipine, or nitroprusside. 
Of these, we excluded 74 patients who received adenosine as part of Fractional Flow Reserve protocol and 6 patients with coronary dissection. We 
performed a complete review of all in hospital events on the remaining 93 patients (mean age 67 years, 83% males) to determine in and out of lab 
complications: congestive heart failure, cardiogenic shock, revisits to catheterization lab, ventricular arrhythmia requiring therapy, death.
Results: Ninety three (2.6%) of the 3542 patients undergoing elective PCI had no reflow/ slow flow during PCI (see detailed table below). Mean 
dose of IC adenosine was 337 micrograms per patient. Four patients received IC nicardipine and 1 patient received IC nitroprusside. Distal 
protection was used in 29 patients of the 56 who underwent graft PCI (59%). There were two graft PCI patients who experienced complications. 
Distal protection was not used in those two patients.
Conclusions: Elective PCI patients rarely experience serious in hospital complications when they develop no reflow/slow flow phenomenon.
In hospital outcomes of the 93 patients with no reflow/ slow flow during elective PCI
Total patients with in-lab no reflow/
slow flow
Death 
Pulmonary edema in lab (required noninvasive 
ventilatory support)
No complications
Vein graft (SVG) 41 1 1 39
SVG + native 
vessel
8 0 0 8
Native vessel via 
SVG
7 0 0 7
Native vessel only 37 0 0 37
Total 93 (100%) 1(1.1%) 1 (1.1%) 91 (97.8%)
